Company
Harton Therapeutics
Biology-first Manufacturing for Scalable Cell Therapy
Also known as Harton, Harton, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- researchers, biotech and pharma teams, and manufacturing partners
- Legal name
- Harton, Inc.
Claim, correct or request removal
Record updated 19 October 2026
About
HT-1 delivers biology-first manufacturing in a closed, GMP-ready platform—combining perfused 3D culture, integrated unit operations, and automated control to deliver high-fidelity human cells from research and development through commercial manufacturing.
Funding snapshot
- Latest round
- Undisclosed, $15.1M2026-07-30
Funding rounds
- Round, 2026
- $15.1M2026-07-30, SEC form D sold
Products
- Hardware
- HT-1
Loading relationship preview